Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Julian Preston

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Toxicologic Pathology|March 14, 2002
Quantitation of molecular endpoints for the dose-response component of cancer risk assessmentR Julian Preston
Health Physics|July 11, 2003
26th Lauriston S. Taylor Lecture: developing mechanistic data for incorporation into cancer and genetic risk assessments: old problems and new approachesR Julian Preston
Toxicology and Applied Pharmacology|August 18, 2004
Children as a sensitive subpopulation for the risk assessment processR Julian Preston
Toxicology and Applied Pharmacology|June 28, 2005
Bystander effects, genomic instability, adaptive response, and cancer risk assessment for radiation and chemical exposuresR Julian Preston
Chemico-Biological Interactions|May 2, 2006
Cancer risk assessment for 1,3-butadiene: data integration opportunitiesR Julian Preston
International Journal of Radiation Biology|February 3, 2017
Can radiation research impact the estimation of risk?R Julian Preston
Critical Reviews in Toxicology|January 19, 2006
DNA-reactive carcinogens: mode of action and human cancer hazardR Julian Preston, Gary M Williams
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 16, 2008
Systems biology and mode of action based risk assessmentStephen W Edwards, R Julian Preston
International Journal of Oncology|August 4, 2005
The effect of arsenicals on ultraviolet-radiation-induced growth arrest and related signaling events in human keratinocytesAnuradha Mudipalli, Russell D Owen, R Julian Preston
Proteomics. Clinical Applications|December 8, 2010
Toxicoproteomics and its application to human health risk assessmentYue Ge, R Julian Preston, Russell D Owen
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Toxicologic Pathology|March 14, 2002
Quantitation of molecular endpoints for the dose-response component of cancer risk assessmentR Julian Preston
Health Physics|July 11, 2003
26th Lauriston S. Taylor Lecture: developing mechanistic data for incorporation into cancer and genetic risk assessments: old problems and new approachesR Julian Preston
Toxicology and Applied Pharmacology|August 18, 2004
Children as a sensitive subpopulation for the risk assessment processR Julian Preston
Toxicology and Applied Pharmacology|June 28, 2005
Bystander effects, genomic instability, adaptive response, and cancer risk assessment for radiation and chemical exposuresR Julian Preston
Chemico-Biological Interactions|May 2, 2006
Cancer risk assessment for 1,3-butadiene: data integration opportunitiesR Julian Preston
International Journal of Radiation Biology|February 3, 2017
Can radiation research impact the estimation of risk?R Julian Preston
Critical Reviews in Toxicology|January 19, 2006
DNA-reactive carcinogens: mode of action and human cancer hazardR Julian Preston, Gary M Williams
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 16, 2008
Systems biology and mode of action based risk assessmentStephen W Edwards, R Julian Preston
International Journal of Oncology|August 4, 2005
The effect of arsenicals on ultraviolet-radiation-induced growth arrest and related signaling events in human keratinocytesAnuradha Mudipalli, Russell D Owen, R Julian Preston
Proteomics. Clinical Applications|December 8, 2010
Toxicoproteomics and its application to human health risk assessmentYue Ge, R Julian Preston, Russell D Owen
Pageof 5